Data and information visualization

'Fujitsu Technology and Service Vision 2024': Leveraging AI and leading-edge technologies to deliver greater value to the environment, economies and people's well-being

Retrieved on: 
木曜日, 5月 23, 2024
Organization, Workforce, SX, Climate change, Ethics, AI, Central processing unit, Service, Data and information visualization, Data analysis, Security, Government, Convergence of random variables, Environment, Computing, Temperature, Management

Fujitsu's vision for 2030 is to become "a technology company that realizes net positive (1) through digital services."

Key Points: 
  • Fujitsu's vision for 2030 is to become "a technology company that realizes net positive (1) through digital services."
  • In its "Fujitsu Technology and Service Vision 2024," Fujitsu positions the "regenerative enterprise" as a new type of organization that utilizes AI and other technologies to create net positive value.
  • Focus will shift from people creating value based on people's knowledge and experience to people and AI collaborating and creating value.
  • To realize this technology vision, Fujitsu focuses its R&D on five key technology areas (Computing, Network, AI, Data & Security, and Converging Technologies).

Grin Unveils First-of-its-Kind 3D Treatment Tracking Tool and More at AAO 2024 Annual Session

Retrieved on: 
金曜日, 5月 3, 2024
Data Analytics, Health, Health Technology, Professional Services, Technology, Apps, Applications, Dental, Mobile, Wireless, Health care, Automation, Innovation Pavilion, Brace, Data and information visualization, Communication, Patient, Treatment, Oral hygiene, AAO, Medical imaging

The Grin 3D Tx Tracker™ empowers practitioners with a more precise method of tracking treatment progress that provides unparalleled insights and control over patient treatment progress.

Key Points: 
  • The Grin 3D Tx Tracker™ empowers practitioners with a more precise method of tracking treatment progress that provides unparalleled insights and control over patient treatment progress.
  • It is a 3D Progression Comparison tool offering precision tracking, representing a significant leap forward in orthodontic treatment monitoring.
  • While remaining completely appliance-agnostic, The Grin 3D Tx Tracker™ is compatible with most major aligner brands and custom digital braces providers.
  • In addition to the new treatment tracking tool, the company is launching a brand-new suite of tools designed to enhance the Grin Premium experience.

Clinical Trial Analytics Services Market Projected to Reach $11.95 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
水曜日, 5月 1, 2024
Deployment, Clinical trial, Investment, Safety, ICON, Machine learning, QIAGEN, Data and information visualization, Collection, Table, Research, Artificial intelligence, Component, ICON PLC, Intelligence, Drug discovery, ChromeOS, Patient, Data collection, Data management, SGS, Health, Drug development, Biomarker, Growth, Pharmaceutical industry

PUNE, India, April 30, 2024 /PRNewswire/ -- The report titled " Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment - Global Forecast 2024-2030 " is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $5.42 billion in 2023 to reach $11.95 billion by 2030, at a CAGR of 11.93% over the forecast period.

Key Points: 
  • PUNE, India, April 30, 2024 /PRNewswire/ -- The report titled " Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment - Global Forecast 2024-2030 " is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $5.42 billion in 2023 to reach $11.95 billion by 2030, at a CAGR of 11.93% over the forecast period.
  • Clinical trial analytics services are revolutionizing the landscape of medical research and drug development across the globe by utilizing cutting-edge data analytics and statistical methodologies to offer invaluable insights from clinical trial data.
  • The Americas lead the market with robust clinical trial activity, supported by Europe's push for more transparent and unified trial regulations.
  • "Dive into the Clinical Trial Analytics Services Market Landscape: Explore 184 Pages of Insights, 574 Tables, and 26 Figures"

Clinical Trial Analytics Services Market Projected to Reach $11.95 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
水曜日, 5月 1, 2024
Deployment, Clinical trial, Investment, Safety, ICON, Machine learning, QIAGEN, Data and information visualization, Collection, Table, Research, Artificial intelligence, Component, ICON PLC, Intelligence, Drug discovery, ChromeOS, Patient, Data collection, Data management, SGS, Health, Drug development, Biomarker, Growth, Pharmaceutical industry

PUNE, India, April 30, 2024 /PRNewswire/ -- The report titled " Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment - Global Forecast 2024-2030 " is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $5.42 billion in 2023 to reach $11.95 billion by 2030, at a CAGR of 11.93% over the forecast period.

Key Points: 
  • PUNE, India, April 30, 2024 /PRNewswire/ -- The report titled " Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment - Global Forecast 2024-2030 " is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $5.42 billion in 2023 to reach $11.95 billion by 2030, at a CAGR of 11.93% over the forecast period.
  • Clinical trial analytics services are revolutionizing the landscape of medical research and drug development across the globe by utilizing cutting-edge data analytics and statistical methodologies to offer invaluable insights from clinical trial data.
  • The Americas lead the market with robust clinical trial activity, supported by Europe's push for more transparent and unified trial regulations.
  • "Dive into the Clinical Trial Analytics Services Market Landscape: Explore 184 Pages of Insights, 574 Tables, and 26 Figures"

Pariveda Achieves AWS Nonprofit Competency Status

Retrieved on: 
火曜日, 2月 13, 2024
Amazon Web Services, Consultant, API, Work, Data and information visualization, Organization, AWS Lambda, Amazon, AWS, Management

DALLAS, Feb. 13, 2024 /PRNewswire/ -- Pariveda, a leading consulting firm dedicated to solving complex business challenges, announced today that it has achieved Amazon Web Services (AWS) Nonprofit Competency status.

Key Points: 
  • DALLAS, Feb. 13, 2024 /PRNewswire/ -- Pariveda, a leading consulting firm dedicated to solving complex business challenges, announced today that it has achieved Amazon Web Services (AWS) Nonprofit Competency status.
  • AWS launched the AWS Nonprofit Competency to help customers find highly specialized AWS Partners with proven customer success and technical proficiency.
  • "Pariveda is proud to achieve AWS Nonprofit Competency status," said Tiffany Lentz, Managing Vice President, Pariveda.
  • To support the seamless integration and deployment of these solutions, AWS established the AWS Competency Program to help customers identify AWS Partners with deep industry experience and expertise.

VISIBLE ALPHA LAUNCHES NEW BIOPHARMA PLATFORM

Retrieved on: 
火曜日, 2月 6, 2024
Growth, Research, Clinical trial, News, Metadata, FDA, MOA, Alpha, Data and information visualization, Pharmaceutical industry

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Visible Alpha, a financial technology company that enhances the investment research process by extracting value from sell-side analyst models, research reports and corporate access events, today announced the launch of its newest data and granular financial information platform Visible Alpha BioPharma.  

Key Points: 
  • NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Visible Alpha, a financial technology company that enhances the investment research process by extracting value from sell-side analyst models, research reports and corporate access events, today announced the launch of its newest data and granular financial information platform Visible Alpha BioPharma.
  • With the launch of Visible Alpha BioPharma, Visible Alpha is providing investment professionals and drug developers with a one-stop-shop for comprehensive drug data and granular financial information to swiftly identify new opportunities, evaluate market competitiveness, gauge market expectations, analyze historical data, access forward-looking estimates and conduct rapid analysis at the drug level.
  • Visible Alpha's new BioPharma platform will allow investment, equity research, and drug development professionals to:
    Gain insights into market trends, investor sentiment and the changing projections surrounding drug performance with detailed financial data.
  • The new Visible Alpha BioPharma platform features the following functionality:
    A Vast Drug Database – Robust forecast data with 200+ brokers, and over a dozen third-party data sources.

VISIBLE ALPHA LAUNCHES NEW BIOPHARMA PLATFORM

Retrieved on: 
火曜日, 2月 6, 2024
Growth, Research, Clinical trial, News, Metadata, FDA, MOA, Alpha, Data and information visualization, Pharmaceutical industry

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Visible Alpha, a financial technology company that enhances the investment research process by extracting value from sell-side analyst models, research reports and corporate access events, today announced the launch of its newest data and granular financial information platform Visible Alpha BioPharma.  

Key Points: 
  • NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Visible Alpha, a financial technology company that enhances the investment research process by extracting value from sell-side analyst models, research reports and corporate access events, today announced the launch of its newest data and granular financial information platform Visible Alpha BioPharma.
  • With the launch of Visible Alpha BioPharma, Visible Alpha is providing investment professionals and drug developers with a one-stop-shop for comprehensive drug data and granular financial information to swiftly identify new opportunities, evaluate market competitiveness, gauge market expectations, analyze historical data, access forward-looking estimates and conduct rapid analysis at the drug level.
  • Visible Alpha's new BioPharma platform will allow investment, equity research, and drug development professionals to:
    Gain insights into market trends, investor sentiment and the changing projections surrounding drug performance with detailed financial data.
  • The new Visible Alpha BioPharma platform features the following functionality:
    A Vast Drug Database – Robust forecast data with 200+ brokers, and over a dozen third-party data sources.

transcosmos Thailand wins 4 awards at TCCTA Contact Center Awards 2023

Retrieved on: 
月曜日, 12月 11, 2023
Ministry, Business process, Data and information visualization, Bronze, Social media, City centre, Best, Gold, Commerce, PDCA, Marketing, CX, BPI, Social Analysis (journal), Digital, Nso people, Partnership, DX, Transcosmos Stadium Nagasaki, Tutoring

TOKYO, Japan, Dec. 10, 2023 /PRNewswire-PRWeb/ -- transcosmos inc. is proud to announce that transcosmos (Thailand) Co., Ltd. (Headquarters: Bangkok, Thailand; Managing Director: Hiroyoshi Hara; transcosmos Thailand), its subsidiary, has made remarkable achievements at the TCCTA Contact Center Awards 2023 hosted by Thai Contact Center Trade Association (TCCTA). In its debut year of participation, transcosmos Thailand achieved remarkable success, securing four awards for the company's commitment to operational excellence and digital transformation (DX) within the contact center industry.

Key Points: 
  • TOKYO, Japan, Dec. 10, 2023 /PRNewswire-PRWeb/ -- transcosmos inc. is proud to announce that transcosmos (Thailand) Co., Ltd. (Headquarters: Bangkok, Thailand; Managing Director: Hiroyoshi Hara; transcosmos Thailand), its subsidiary, has made remarkable achievements at the TCCTA Contact Center Awards 2023 hosted by Thai Contact Center Trade Association (TCCTA).
  • transcosmos Thailand extends its gratitude to the TCCTA Contact Center Awards 2023 for this recognition and looks forward to continuing its journey of providing exceptional customer service and being the Global Digital Transformation Partner for clients.
  • The TCCTA recognizes and rewards contact center businesses that have displayed their commitment to provide high quality services during the year at its annual TCCTA Contact Center Awards.
  • transcosmos Thailand extends its gratitude to the TCCTA Contact Center Awards 2023 for this recognition and looks forward to continuing its journey of providing exceptional customer service and being the Global Digital Transformation Partner for clients.

Big Data Analytics in Semiconductor & Electronics Market Size to Grow USD 47.2 Billion by 2031 at a CAGR of 9.9% | Valuates Reports

Retrieved on: 
水曜日, 10月 18, 2023
Predictive maintenance, Sales, Data wrangling, Data mining, Big data, Data and information visualization, Organization, Projection, Acquisition, Tame (analytic tool), Software, Tablet, Process optimization, Growth, Classification, Dashboard, Business, Customer analytics, Component, USD, Investment, Marketing, Semiconductor, Longevity, Software as a service, Retail, Electronics, Service

The global Big Data Analytics in Semiconductor & Electronics market was valued at USD 18.7 Billion in 2021, and is projected to reach USD 47.2 Billion by 2031, growing at a CAGR of 9.9% from 2022 to 2031.

Key Points: 
  • The global Big Data Analytics in Semiconductor & Electronics market was valued at USD 18.7 Billion in 2021, and is projected to reach USD 47.2 Billion by 2031, growing at a CAGR of 9.9% from 2022 to 2031.
  • The expansion of big data analytics in the semiconductor and electronics sector is also positively impacted by a number of advantages offered by big data and business analytics, such as quicker data processing.
  • Instead, businesses are implementing big data analytics to improve the client experience, which greatly aids in the expansion of the Big Data Analytics Semiconductor & Electronics Market.
  • By examining consumer preferences, market trends, and feedback data, big data analytics in semiconductors and electronics aids product innovation.

Big Data Analytics in Semiconductor & Electronics Market Size to Grow USD 47.2 Billion by 2031 at a CAGR of 9.9% | Valuates Reports

Retrieved on: 
水曜日, 10月 18, 2023
Predictive maintenance, Sales, Data wrangling, Data mining, Big data, Data and information visualization, Organization, Projection, Acquisition, Tame (analytic tool), Software, Tablet, Process optimization, Growth, Classification, Dashboard, Business, Customer analytics, Component, USD, Investment, Marketing, Semiconductor, Longevity, Software as a service, Retail, Electronics, Service

The global Big Data Analytics in Semiconductor & Electronics market was valued at USD 18.7 Billion in 2021, and is projected to reach USD 47.2 Billion by 2031, growing at a CAGR of 9.9% from 2022 to 2031.

Key Points: 
  • The global Big Data Analytics in Semiconductor & Electronics market was valued at USD 18.7 Billion in 2021, and is projected to reach USD 47.2 Billion by 2031, growing at a CAGR of 9.9% from 2022 to 2031.
  • The expansion of big data analytics in the semiconductor and electronics sector is also positively impacted by a number of advantages offered by big data and business analytics, such as quicker data processing.
  • Instead, businesses are implementing big data analytics to improve the client experience, which greatly aids in the expansion of the Big Data Analytics Semiconductor & Electronics Market.
  • By examining consumer preferences, market trends, and feedback data, big data analytics in semiconductors and electronics aids product innovation.